GemVax & KAEL Co. Ltd. | Income Statement
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
66,530
101,051
75,074
28,403
47,875
Cost of Goods Sold (COGS) incl. D&A
53,276
80,848
59,886
19,147
31,627
Gross Income
13,254
20,203
15,188
9,255
16,248
SG&A Expense
23,527
25,942
17,486
15,485
17,663
EBIT
10,547
5,927
2,657
-
1,415
Unusual Expense
3,233
11,166
5,267
-
-
Non Operating Income/Expense
349
183
300
3,842
6,893
Interest Expense
6,807
4,286
4,128
2,843
13,937
Pretax Income
13,130
21,306
11,491
15,736
30,413
Income Tax
690
1,019
2,243
1,501
-
Equity in Affiliates
-
7,510
249
-
-
Consolidated Net Income
13,819
29,834
9,497
17,237
30,413
Net Income
11,482
31,997
2,453
17,237
30,413
Net Income After Extraordinaries
21,953
31,997
2,453
13,528
48,554
Net Income Available to Common
14,673
31,997
2,453
20,947
12,272
EPS (Basic)
40.00
908.00
87.00
700.00
403.00
Basic Shares Outstanding
25
35
28
30
30
EPS (Diluted)
39.35
907.65
87.01
700.11
403.26
Diluted Shares Outstanding
26
35
28
30
30
EBITDA
6,817
1,628
2,279
401
1,495
Other Operating Expense
274
189
358
-
-
Non-Operating Interest Income
642
256
261
1,100
5,417
Minority Interest Expense
2,338
2,163
7,044
-
-
Equity in Affiliates (Pretax)
-
-
-
3,922
13,586
About GemVax & KAEL Co.
View Profile
